Replies to post #128414 on Vivos Inc (RDGL)

[tilltom]

The best Korenko can do is treat a few animals a year at zero profit. He has little to no interest in the Reg. A. and the market has zero interest in buying this. Its been circling the toilet for years with little to no progress. It's light-years away from human treatment. It can't even get out of Korenkos basement and have a real office. It's the 2 cent cancer cure nobody wants. If it had anything worth acquiring big pharma would have bought this out long ago. Its going noplace fast.

[WALLnut]

Things to remember in human trials is one, the yttrium istope is already approved by FDA for human use. Its the gel that needs approval. And two, after phase 1 is completed Radiogel can be used in Right To Try patients that have internal or external cancers.

Skin cancer is their first indication of 18 and probably the easiest and most wide spread cancers to treat in the world. It's were the money is.

And the third, pet data will help speed up human trial phases immensely. They have a great deal of data to feed FDA in thier submissions.

Money is a problem but cleaning up the books after Jim K. has been a huge huge drawback while Korenko tries to move us forward. Doc is battling two fires, one behind and one in front. And I think he'll put them both out with great success.

It gets better from here. I truly believe that.